The laboratory directed by CNR researcher Dr. Marianna Leonzino in the "Area Neuro" of the Humanitas Research Hospital is seeking talented and highly motivated researchers at all career stages. Successful applicants will join a vibrant young team working on the role of interorganellar communication in neurodegenerative diseases and will contribute to a project aimed at dissecting cellular pathways leading to neuronal death in the context of Amyotrophic Lateral Sclerosis (ALS). The project is part of a collaborative effort involving also the lab of Dr. Paolo Colombi (IGM-CNR). The team uses human IPSC-derived neurons as a cellular model and takes advantage of gene-editing techniques to develop disease-modeling cell lines.

Institut Curie is recruiting a PhD Program Manager. Position based in Paris, 5th arrondissement.

Concorso pubblico, per titoli ed esami, per l’assunzione a tempo determinato di un COLLABORATORE PROFESSIONALE DI RICERCA SANITARIA - AREA PER IL TRASFERIMENTO TECNOLOGICO del CRO di Aviano (PN)

We are recruiting at all levels of seniority (postgraduate, PhD, postdoc) to join our lab at the Humanitas Research Hospital to study the role of genome integrity in memory T cell differentiation and immunosuppression. Humanitas hosts a scientific community of more than 300 scientists with interests ranging from immunology to genomics, cardiovascular biology and neurobiology and is one of the most visible and expanding research centers in Italy.

The Ostuni lab combines advanced single-cell and spatial genomics on human samples with mechanistic studies in the mouse to elucidate how microenvironmental factors shape the behavior of innate immune cells. Over the years, we contributed to the understanding of the molecular control and functional implications of macrophage and neutrophil diversity in homeostasis and cancer. Our research has been published in top scientific journals and is funded by the most prestigious agencies such as the European Research Council (ERC-StG, ERC-CoG, ERC-PoC). Our vision is that by taking an interdisciplinary approach to understand biology we will develop the next generation of cell and gene therapies for immune-mediated human diseases, such as cancer. In our group, wet-lab and computational scientists engage in a virtuous cycle whereby biology instructs data analysis and data analysis fuels experimental hypothesis.